🎙️ Podcast Version The multiple risks in NAFLD by Prof. F. Tacke

🎙️ podcast version

The multiple risks in NAFLD by Prof. F. Tacke

In NAFLD, the liver is both victim and motor of a multisystem disease. Liver disease is not limited to the liver itself but has an impact on glycemic control in the body. Prof. Tacke discusses this vicious cycle and how NAFLD may add to coexisting risk factors and is predictor of morbidity and mortality. He shows why this is also important to develop new treatment strategies.
Avatar photo

Prof. Frank Tacke

Frank Tacke was originally educated at the medical school in Hannover, Germany, and Baylor College of Medicine, Houston, TX. Later he stayed at University of Texas, M.D. Anderson Cancer Center in Houston, working on new gene therapy strategies (1998-1999) as well as for a post-doctoral research training (2004-2006) at the Mount Sinai Medical Center, New York, working on monocyte/macrophage and dendritic cell biology. Since 2006, he is a clinical physician and leader of a research laboratory at the University Hospital Aachen, Germany.

Delving into the Latest Advancements in MASLD Treatment: Key Insights from Prof. Wong’s presentations at AASLD

Explore Prof. Wong's insights on MASLD treatment advancements from AASLD, featuring key drugs like Resmetirom, Lanifibranor, and Semaglutide with a…

International NASH Day 2023: Empowering Healthcare Professionals

On International NASH Day 2023, PanNASH amplifies the importance of NASH awareness, education, and action. Learn about the complex multisystem…

Nordic NASH Symposium

PanNASH speaker; Dr. Stephen Harrison takes part in the Nordic NASH symposium which aims to discuss management and diagnosis strategies…

The role of circadian clocks in the pathogenesis of NAFLD

The circadian clock controls rhythms responsible for regulating bodily functions, e.g., appropriate eating times. When this clock becomes disrupted due…

Hepatocellular carcinoma surveillance in NAFLD patients

Nonalcoholic fatty liver disease (NAFLD) is characterised by the presence of hepatic steatosis without significant alcohol consumption or concomitant liver…

MAFLD and inflammatory bowel disease: a prospective cohort study

MAFLD and inflammatory bowel disease: a prospective cohort study

Coffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model

Coffee achieves its beneficial effects through modulation of insulin resistance in a NAFLD mouse model

B cells aggravate NASH: an innate and adaptive signalling

In this study, F. Barrow et al. (University of Minnesota Medical School, Minneapolis, USA) report that NASH livers accumulate B…

NAFLD: from drivers to targets

In this review, A. Santos-Laso et al. (Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute, Santander, Spain) summarise the…

NASH: an Overview Through 200 Years of Clinical Research

Although the term 'fatty liver hepatitis' first appeared in 1962, it was in 1980 that the term 'non-alcoholic steatohepatitis' (NASH)…

Immune cell-mediated features of NASH

In this review, T. Huby and E. L. Gautier (Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France) discuss “current concepts…

Steatohepatitis: hypothesis for a pathomechanism

In this article, P. M. Abuja et al. (Medical University of Graz, Austria) propose that steatohepatitis develops in four phases…

SUBSCRIBE & FOLLOW US

Subscribe Our Newsletter To Get the Lastest Updates

Related Videos